Cardiomyopathy
Conditions
Interventions
Observation group:None
Sponsors
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years. 2.Patients diagnosed with cardiomyopathy. Diagnosis is confirmed through one or more methods in the cardiomyopathy screening process, including clinical evaluation, imaging, laboratory tests, or pathological examination). This includes conditions such as hypertrophic cardiomyopathy, dilated cardiomyopathy, metabolic cardiomyopathy, and restrictive cardiomyopathy. 3.Provide informed consent to participate.
Exclusion criteria
Exclusion criteria: 1.Acute or chronic renal impairment (GFR < 50 mL/min/1.73m^2; 2.Subjects with other coexisting cardiac conditions (e.g., established valvular heart disease, congenital heart disease); 3.Development of other conditions potentially leading to heart failure during the follow-up, including but not limited to new acute myocardial infarction, exposure to cardiotoxic medications, or infections resulting in endocarditis. 4.Any comorbid condition that, in the investigator's opinion, poses a serious risk to patient safety or compromises study compliance (e.g., life expectancy <6 months, uncontrolled diabetic ketoacidosis, active systemic infection, or thyroid disease);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac ultrasound / myocardial magnetic resonance / myocardial biopsy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Collection of basic information(Age/Gender/ Vital Signs, etc.);Laboratory tests (troponin/BNP, etc.); | — |
Countries
China
Contacts
Public ContactJun Pu
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Outcome results
None listed